The American Society of Ketamine Physicians, Psychotherapists, and Practitioners (ASKP3) is a non-profit organization that establishes ethical standards and guidelines for the clinical use of ketamine in treating mental health disorders and pain conditions. By fostering interdisciplinary collaboration and providing education, ASKP3 aims to enhance patient safety and treatment efficacy in a field marked by variability in practice.
Funding
Funding not disclosed
Founders
Product
Problem
The use of ketamine for mental health disorders and pain conditions lacks standardized practices, leading to variability in treatment protocols and potential risks to patient safety. The absence of clear guidelines and ethical standards can result in inconsistent care and compromise the efficacy of ketamine therapy.
Solution
The American Society of Ketamine Physicians, Psychotherapists, and Practitioners (ASKP3) establishes ethical standards and guidelines for the clinical use of ketamine in treating mental health disorders and pain conditions. ASKP3 fosters interdisciplinary collaboration among physicians, psychotherapists, and practitioners to promote patient safety and treatment efficacy. The organization provides educational resources, publishes practical standards, and facilitates the exchange of ideas and research to advance the quality of care. ASKP3 aims to build awareness and understanding among clinical communities, legislators, regulators, payers, and the general population regarding ketamine therapy and emerging psychedelic treatments.
Target Audience
The primary audience includes physicians, psychotherapists, practitioners, researchers, legislators, regulators, and payers involved in the clinical use of ketamine for mental health disorders and pain conditions.
Features
- Establishes scientific, ethical, and transparent standards for ketamine practitioners.
- Advances the quality of care through knowledge dissemination, idea exchange, and research initiatives.
- Fosters multidisciplinary collaboration to improve patient outcomes.
- Educates clinical communities on all aspects of ketamine treatment modalities.
- Builds awareness and understanding among the general public, legislators, regulators, and payers.
- Welcomes relationships that support the development of other psychedelic therapies.
- Publishes practical and ethical standards for ketamine therapy.
- Creates guidelines for at-home ketamine use, emphasizing specific patient profiles and close provider relationships.
- Offers a directory of members and resources, including scientific literature and webinars.